F
Notable Labs, Ltd. NTBLQ
$0.00 $0.000.00% OTC PK
Recommendation
Prev Close
$0.000001
Volume
4
Avg Vol (90D)
9,876
Market Cap
$9.00
Dividend & Yield
--
52-Week Range
$0.00 - $1.84
P/E (TTM)
0.00
EPS (TTM)
-$1.28
My Lists My Alerts
Access our Premium Ratings
Get Access
Rating
Reward
Risk
Rating Factors
Growth Index
Efficiency Index
Solvency Index
Total Return Index
Volatility Index
Dividend Index
Headlines
There are no news to display.
Income Statement
Total Revenue (TTM)
$313.00K
EBITDA (TTM)
-$15.12M
EBIT (TTM)
-$15.37M
Net Income (TTM)
-$10.54M
Balance Sheet
Total Assets (Q)
$11.00M
Total Debt (Q)
$1.80M
Total Liabilities (Q)
$3.82M
Book Value Per Share (Q)
$0.7439
Cash Flow
Cash from Operations (TTM)
-$15.15M
Cash from Investing (TTM)
$15.56M
Cash from Financing (TTM)
$1.30M
Net Change in Cash (TTM)
$2.20M
Filings
Filing Date
Wednesday, August 14, 2024
Period Date
Sunday, June 30, 2024
Next Filing
(est)
Price History
Loading...
Beta
--
7-Day Total Return
--
30-Day Total Return
--
60-Day Total Return
-99.00%
90-Day Total Return
-100.00%
Year to Date Total Return
-100.00%
1-Year Total Return
-100.00%
2-Year Total Return
--
3-Year Total Return
--
5-Year Total Return
--
52-week Low
Feb 07, 2025 - $0.00
52-week High
May 09, 2024 - $1.84
Valuation
Market Cap
$9.00 - Nano Cap
Enterprise Value
-$2.30M
Price/Sales (TTM)
0.00
Price/Book (Q)
0.00
Dividends and Shares
Shares Outstanding
9.46M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.notablelabs.com
Phone Number
415 851 2410
Address
320 Hatch Drive
Foster City, CA 94404
Country
United States
Year Founded
2014
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Notable Labs, Ltd., a clinical-stage platform therapeutics company, develops predictive precision medicines for patients with cancer. The company, through its proprietary Predictive Precision... more
OTC PK 04/22/2025 11:05AM Eastern Quotes delayed